Urologists Discredit Flawed, Misleading GAO Cancer Treatment Utilization Study
Urologists refuted the Government Accountability Office’s (GAO) flawed and misleading study on the use of intensity-modulated radiation therapy (IMRT) for the treatment of prostate cancer. To read the story, please click here.
Urologists Applaud Members Of Congress For Their Strong Support For Preserving The In-Office Ancillary Services Exception (IOASE)
In a letter to Speaker John Boehner and Democratic Leader Nancy Pelosi, 17 members of the Physician’s Caucus expressed their support for the in-office ancillary services exception (IOASE) to federal self-referral regulations (the “Stark” law), which permits physician practices to provide critical services including radiation therapy, diagnostic imaging, pathology and physical therapy in an integrated and coordinated fashion within their respective practices. “Providing comprehensive services to patients through integration of ancillary services improves communications between physicians of different specialties, and will lead to improved quality care at reduced costs”, said Dr. Deepak A. Kapoor.
To read the article, please click here.
Don’t Cancel In-Office Prostate Cancer Treatments
Dr. Deepak A. Kapoor discusses why repealing the in-office ancillary services exception would devastate prostate cancer victims receiving intensity-modulated radiation therapy (IMRT) treatments. Clearly, it makes no sense to close the in-office, more affordable treatment sites in favor of more expensive ones (hospitals).